Hijos de Rivera, en alianza con la Xunta de Galicia a través de Xesgalicia e Inproteins, ha puesto en marcha un ambicioso proyecto para impulsar la producción de proteínas vegetales en Galicia. Con...
Venture capital remains the main source of investment for startups and scaleups, with nearly €278 million (80% of the total). This figure is notably higher than the previous year, thanks in part to ...
Business growth is therefore a continuous process that requires well-defined strategies and effective management of challenges. Both organic and inorganic growth offer unique opportunities, but also p...
Europa necesita realizar una apuesta por la inversión en “tecnologías disruptivas” y en ciencia, en una alianza de la iniciativa pública y del capital privado, para poder garantizarse la “sob...
BioSintNA incluirá en su formulación acciones de promoción y visibilidad, formación y talento, fomento y desarrollo del tejido empresarial, regulación y ética, sostenibilidad del modelo de negoc...
Avamed Synergy abre una nueva ronda de financiación de cinco millones de euros. El objetivo es acabar de sufragar las pruebas piloto de su desarrollo Fluxus y adquirir la “fortaleza financiera” a...
The offering, which was structured as straight equity with no warrants attached, attracted strong demand and was significantly oversubscribed. A US-based institutional investor anchored the round with...
España se sitúa como el cuarto país en inversión total en sanidad pública en Europa, con 134 mil millones de euros, superada solo por Alemania (489 mil millones), Francia (313 mil millones) e Ita...
Libera Bio has announced that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic. Investors include Xesgalicia, Semola Tech Ventures, ROSP Co...
The company previously closed a €650,000 pre-seed round in April 2023 through Capital Cell, complemented by an ENISA participatory loan and NextGeneration-EU grants, reaching a total accumulated fun...
FreeOx has developed the first cerebroprotective therapy designed to preserve the brain during acute ischemic stroke. It is the key piece in stroke treatment, as it focuses on microcirculation and sol...
The transaction brings in GIMIC Ventures, a venture capital fund based in Karlsruhe as a new institutional investor, along with several private family offices. This funding represents a transformative...